These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 36127416
1. Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial. Guido A, Cuicchi D, Castellucci P, Cellini F, Di Fabio F, Llimpe FLR, Strigari L, Buwenge M, Cilla S, Deodato F, Macchia G, Galietta E, Golfieri R, Ardizzoni A, Zagari RM, Fanti S, Poggioli G, Fuccio L, Morganti AG. Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):572-580. PubMed ID: 36127416 [Abstract] [Full Text] [Related]
2. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer. Altini C, Niccoli Asabella A, De Luca R, Fanelli M, Caliandro C, Quartuccio N, Rubini D, Cistaro A, Montemurro S, Rubini G. Abdom Imaging; 2015 Jun; 40(5):1190-202. PubMed ID: 25348731 [Abstract] [Full Text] [Related]
3. The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer. Sun W, Xu J, Hu W, Zhang Z, Shen W. Colorectal Dis; 2013 May; 15(5):e231-8. PubMed ID: 23384167 [Abstract] [Full Text] [Related]
4. Prognostic utility of serial 18F-FDG-PET/CT in patients with locally advanced rectal cancer who underwent tri-modality treatment. Fernando S, Lin M, Pham TT, Chong S, Ip E, Wong K, Chua W, Ng W, Lin P, Lim S. Br J Radiol; 2020 Jan; 93(1105):20190455. PubMed ID: 31617737 [Abstract] [Full Text] [Related]
5. Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer? Deantonio L, Caroli A, Puta E, Ferrante D, Apicella F, Turri L, Sacchetti G, Brambilla M, Krengli M. Radiat Oncol; 2018 Oct 25; 13(1):211. PubMed ID: 30359275 [Abstract] [Full Text] [Related]
6. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study. Li QW, Zheng RL, Ling YH, Wang QX, Xiao WW, Zeng ZF, Fan W, Li LR, Gao YH. Abdom Radiol (NY); 2016 Aug 25; 41(8):1448-55. PubMed ID: 27116012 [Abstract] [Full Text] [Related]
7. The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. Sakin A, Sahin S, Karyagar SS, Karyagar S, Atci M, Akboru MH, Cihan S. J Gastrointest Cancer; 2022 Jun 25; 53(2):341-347. PubMed ID: 33651265 [Abstract] [Full Text] [Related]
8. Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy. Maffione AM, Ferretti A, Grassetto G, Bellan E, Capirci C, Chondrogiannis S, Gava M, Marzola MC, Rampin L, Bondesan C, Colletti PM, Rubello D. Eur J Nucl Med Mol Imaging; 2013 Jun 25; 40(6):853-64. PubMed ID: 23417501 [Abstract] [Full Text] [Related]
9. Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Chennupati SK, Quon A, Kamaya A, Pai RK, La T, Krakow TE, Graves E, Koong AC, Chang DT. Am J Clin Oncol; 2012 Aug 25; 35(4):334-9. PubMed ID: 21422989 [Abstract] [Full Text] [Related]
10. Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer. Alongi F, Fersino S, Mazzola R, Fiorentino A, Giaj-Levra N, Ricchetti F, Ruggieri R, Di Paola G, Cirillo M, Gori S, Salgarello M, Zamboni G, Ruffo G. Clin Transl Oncol; 2017 Feb 25; 19(2):189-196. PubMed ID: 27271749 [Abstract] [Full Text] [Related]
11. The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer. Murcia Duréndez MJ, Frutos Esteban L, Luján J, Frutos MD, Valero G, Navarro Fernández JL, Mohamed Salem L, Ruiz Merino G, Claver Valderas MA. Eur J Nucl Med Mol Imaging; 2013 Jan 25; 40(1):91-7. PubMed ID: 23081822 [Abstract] [Full Text] [Related]
12. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer. Yoon HJ, Kim SK, Kim TS, Im HJ, Lee ES, Kim HC, Park JW, Chang HJ, Choi HS, Kim DY, Oh JH. Clin Nucl Med; 2013 Jan 25; 38(1):7-12. PubMed ID: 23242038 [Abstract] [Full Text] [Related]
13. Value of volumetric and textural analysis in predicting the treatment response in patients with locally advanced rectal cancer. Karahan Şen NP, Aksu A, Kaya GÇ. Ann Nucl Med; 2020 Dec 25; 34(12):960-967. PubMed ID: 32951129 [Abstract] [Full Text] [Related]
15. The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery. Capirci C, Rubello D, Pasini F, Galeotti F, Bianchini E, Del Favero G, Panzavolta R, Crepaldi G, Rampin L, Facci E, Gava M, Banti E, Marano G. Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1461-9. PubMed ID: 19419820 [Abstract] [Full Text] [Related]
17. FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. Lovinfosse P, Polus M, Van Daele D, Martinive P, Daenen F, Hatt M, Visvikis D, Koopmansch B, Lambert F, Coimbra C, Seidel L, Albert A, Delvenne P, Hustinx R. Eur J Nucl Med Mol Imaging; 2018 Mar 01; 45(3):365-375. PubMed ID: 29046927 [Abstract] [Full Text] [Related]
18. Predictive value of 18F-FDG PET/CT on survival in locally advanced rectal cancer after neoadjuvant chemoradiation. Niccoli Asabella A, Simone M, Ballini A, Altini C, Ferrari C, Lavelli V, De Luca R, Inchingolo F, Rubini G. Eur Rev Med Pharmacol Sci; 2018 Dec 01; 22(23):8227-8236. PubMed ID: 30556862 [Abstract] [Full Text] [Related]